Alpelisib-Induced Diabetic Ketoacidosis and Insulin-Resistant Hyperglycemia
Diabetic ketoacidosis is a rare complication of alpelisib initiation, which is quickly resolved with cessation of the agent. For patients where cessation is not an option, insulin and insulin sensitizing agents can be used to achieve glycemic control at the potential detriment of tumor treatment.
Authors
- Vishal Sehgal (ORCID: https://orcid.org/0000-0001-5171-217X)
- Niraj Gupta (ORCID: https://orcid.org/0000-0003-1078-5385)
- Michael Loke
Institutions
- St. Vincent Hospital (US)
Publication Details
- Journal
- AACE Clinical Case Reports
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.aace.2024.10.002
- Citations
- 3
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.72